These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16201020)

  • 21. Vibrio cholerae infection, novel drug targets and phage therapy.
    Fazil MH; Singh DV
    Future Microbiol; 2011 Oct; 6(10):1199-208. PubMed ID: 22004038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and environmental isolates of Vibrio cholerae serogroup O141 carry the CTX phage and the genes encoding the toxin-coregulated pili.
    Dalsgaard A; Serichantalergs O; Forslund A; Lin W; Mekalanos J; Mintz E; Shimada T; Wells JG
    J Clin Microbiol; 2001 Nov; 39(11):4086-92. PubMed ID: 11682534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ToxR regulon of Vibrio cholerae and its expression in vibrios shed by cholera patients.
    Bina J; Zhu J; Dziejman M; Faruque S; Calderwood S; Mekalanos J
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2801-6. PubMed ID: 12601157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice.
    Rollenhagen JE; Kalsy A; Cerda F; John M; Harris JB; Larocque RC; Qadri F; Calderwood SB; Taylor RK; Ryan ET
    Infect Immun; 2006 Oct; 74(10):5834-9. PubMed ID: 16988262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional responses of intestinal epithelial cells to infection with Vibrio cholerae.
    Stokes NR; Zhou X; Meltzer SJ; Kaper JB
    Infect Immun; 2004 Jul; 72(7):4240-8. PubMed ID: 15213169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-genome sequence comparisons reveal the evolution of Vibrio cholerae O1.
    Kim EJ; Lee CH; Nair GB; Kim DW
    Trends Microbiol; 2015 Aug; 23(8):479-89. PubMed ID: 25913612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response of Vibrio cholerae to the Catecholamine Hormones Epinephrine and Norepinephrine.
    Halang P; Toulouse C; Geißel B; Michel B; Flauger B; Müller M; Voegele RT; Stefanski V; Steuber J
    J Bacteriol; 2015 Dec; 197(24):3769-78. PubMed ID: 26416829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemolysin and the multifunctional autoprocessing RTX toxin are virulence factors during intestinal infection of mice with Vibrio cholerae El Tor O1 strains.
    Olivier V; Haines GK; Tan Y; Satchell KJ
    Infect Immun; 2007 Oct; 75(10):5035-42. PubMed ID: 17698573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism for inhibition of Vibrio cholerae ToxT activity by the unsaturated fatty acid components of bile.
    Plecha SC; Withey JH
    J Bacteriol; 2015 May; 197(10):1716-25. PubMed ID: 25733618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A colonization factor links Vibrio cholerae environmental survival and human infection.
    Kirn TJ; Jude BA; Taylor RK
    Nature; 2005 Dec; 438(7069):863-6. PubMed ID: 16341015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hybrid microarray based on double biomolecular markers of DNA and carbohydrate for simultaneous genotypic and phenotypic detection of cholera toxin-producing Vibrio cholerae.
    Shin HH; Seo JH; Kim CS; Hwang BH; Cha HJ
    Biosens Bioelectron; 2016 May; 79():398-405. PubMed ID: 26735874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on Environmental and Host Factors Impacting the Risk of
    Chac D; Dunmire CN; Singh J; Weil AA
    ACS Infect Dis; 2021 May; 7(5):1010-1019. PubMed ID: 33844507
    [No Abstract]   [Full Text] [Related]  

  • 34. An Adult Mouse Model of
    Sawasvirojwong S; Srimanote P; Chatsudthipong V; Muanprasat C
    PLoS Negl Trop Dis; 2013 Jun; 7(6):e2293. PubMed ID: 23826402
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Montero DA; Vidal RM; Velasco J; George S; Lucero Y; Gómez LA; Carreño LJ; García-Betancourt R; O'Ryan M
    Front Med (Lausanne); 2023; 10():1155751. PubMed ID: 37215733
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic analysis of Drosophila melanogaster susceptibility to intestinal Vibrio cholerae infection.
    Berkey CD; Blow N; Watnick PI
    Cell Microbiol; 2009 Mar; 11(3):461-74. PubMed ID: 19046341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infant Rabbit Model for Diarrheal Diseases.
    Abel S; Waldor MK
    Curr Protoc Microbiol; 2015 Aug; 38():6A.6.1-15. PubMed ID: 26237109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The acetate switch of an intestinal pathogen disrupts host insulin signaling and lipid metabolism.
    Hang S; Purdy AE; Robins WP; Wang Z; Mandal M; Chang S; Mekalanos JJ; Watnick PI
    Cell Host Microbe; 2014 Nov; 16(5):592-604. PubMed ID: 25525791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vibrio cholerae as a predator: lessons from evolutionary principles.
    Pukatzki S; Provenzano D
    Front Microbiol; 2013; 4():384. PubMed ID: 24368907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MakC and MakD are two proteins associated with a tripartite toxin of
    Bodra N; Toh E; Nadeem A; Wai SN; Persson K
    Front Microbiol; 2024; 15():1457850. PubMed ID: 39421563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.